Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724397 | SCV000231397 | uncertain significance | not provided | 2014-12-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000724397 | SCV000715871 | benign | not provided | 2019-02-27 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001086358 | SCV000771433 | benign | Charcot-Marie-Tooth disease axonal type 2O | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002314658 | SCV000848792 | likely benign | Inborn genetic diseases | 2017-01-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Athena Diagnostics | RCV000724397 | SCV001143802 | benign | not provided | 2018-11-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000724397 | SCV003917345 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | DYNC1H1: BP4, BP7, BS1 |
Clinical Genetics, |
RCV000724397 | SCV001923230 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000724397 | SCV001972053 | likely benign | not provided | no assertion criteria provided | clinical testing |